Human Microbiome-based Gut Health Test and Nutrition Market

Human Microbiome-based Gut Health Test and Nutrition Market worth US$ 885.52 Million by 2030 - Exclusive Report by InsightAce Analytic

The "Global Human Microbiome-based Gut Health Test and Nutrition Market - By Product (D2C Gut Health Test, Probiotic Supplements, Personalized Nutrition, Microbiome Modulators) and Future Trends, Industry Competition Analysis, Revenue and Forecast To 2030" market assessment report has been released by InsightAce Analytic Pvt. Ltd.

According to the latest research report, the global human microbiome-based gut health test and nutrition market is valued at US$ 110.83 Million in 2021, and it is expected to reach US$ 885.52 Million by 2030, with a CAGR of 27.2% during the forecast period of 2022-2030. By Region, North America dominated the market with a significant share in 2021.

Get Free Access to Demo Report, Excel Pivot and ToC: www.insightaceanalytic.com/request-sample/1221

A collection of both advantageous and detrimental bacteria found in the digestive tract of humans is known as the human gut microbiome. The human stomach is home to thousands of different species of microorganisms, including viruses, fungus, bacteria, and parasites. Through the breakdown of potentially harmful dietary substances and the synthesis of particular vitamins and amino acids, such as all B vitamins and vitamin K, microbiota helps the immune system. Gut health test kits, which use stool tests to diagnose the population and health, are used to diagnose human gut health. Both individualized results and suggestions for extra dietary supplements are provided by these tests. Immunity, physical and mental well-being, and other advantages depend on gut health and the right ratio of these microbes.
The COVID-19 impact increased consumer awareness of the significance of gut health, gut immunity, and gut health testing, which will influence gut microbiome nutrition research and production. Growing knowledge of the microbiota's function in illness development and the quick development of microbiome diagnostic testing are anticipated to propel market expansion over the forecast period. Additionally, the expansion of the worldwide market will be significantly influenced by biotechs, creative start-ups, and multinational consumer packaged goods (CPG) firms. Throughout the forecast period, there could be significant development prospects due to the growing number of public-private cooperation.
Nonetheless, it is anticipated that a high consumption of antibiotics and other supplements will hurt the worldwide industry. The wide variation in human genetic makeup, dietary practices, and geographic dispersion around the world makes it difficult to understand the gut microbiota.
During the projected period (2022-2030), North America is expected to have significant growth due to the massive influence of COVID-19 and increased demand. Companies are given enormous funds to investigate live microbiome ingredients and develop new products.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

The important key players are Seed Health, ResBiotic, Fitbiomics, HSK Genetech, Mybacs, Affinity DNA, Freshly fermented, Carbiotix, Troo, Verisana, Throne, Phable, Biomesight, Invivo, Neovos, Holobiome, The BioArte, Bio & Me, ISOThrive, Zarbees, Mamasselect, Hyperbiotics, Everidis, Floraster, Enfamil, Culturelle, Biogaia, Viome, Atlas Biomed, Nouri, Bayer Consumer Health, Clasado Biosciences, CometBio, Essential formulae, ExeGi, Kerry, Immune Biotech, Pendulum Therapeutics, Evolve Biosystems, Gerber, Lovebug probiotics, Mommy's Bliss, Flore, Bioms, Ombre, Biohm, Nexbiome, Finch Therapeutics, Byheart, Mybiotics, Vedanta Biosciences, Other Prominent Players

Key developments in the market:
• In Jan 2022, Unilever has associated with the gut microbiome specialists at Holobiome to identify food & drink ingredients that could have a positive effect on mental wellbeing by targeting the gut-brain axis. The research partnership between Unilever and Holobiome attempts to find specific dietary ingredients that interact with these important bacteria. The long-term goal is to use these substances in a variety of foods and beverage products across Unilever's portfolio to naturally increase levels of calming neurotransmitters in the gut, so enhancing mental health.

• In Nov 2021, Ombre raised $3M seed round for at-home microbiome tests. Ombre will emphasis on improving its existing products, supply chain, and services and home tests, gut health reports, probiotic formulations, and in-app experience.

• In Nov 2020, Cargill invested US$25m in BioGaia, microbiome collaborations to follow and to accelerate growth and expand microbiome solutions. Cargill Health Technologies (CHT) will benefit from the investment as it expands its offering of health solutions for consumers.

• In Dec 2019, RB and Evolve BioSystems Team Up to Advance Infant Gut Health to sell 'Evivo', which is clinically proven to reduce gut pH, thereby helping suppress the growth of pathogenic bacteria in the infant's gut.

Unlock Your GTM Strategy: www.insightaceanalytic.com/customisation/1221

Market Segmentation
Global Human Microbiome-based Gut Health Test and Nutrition Market, by Products, 2022-2030 (Value US$ Mn)
• D2C Gut Health Test
• Probiotic Supplements
• Personalized Nutrition
• Microbiome Modulators
o Ingredients
o Medical Foods
o Therapeutics
Global Human Microbiome-based Gut Health Test and Nutrition Market, by End-User, 2022-2030 (Value US$ Mn)
• Adult
• Maternal
• Infant
Global Human Microbiome-based Gut Health Test and Nutrition Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Human Microbiome-based Gut Health Test and Nutrition Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Human Microbiome-based Gut Health Test and Nutrition Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Human Microbiome-based Gut Health Test and Nutrition Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Human Microbiome-based Gut Health Test and Nutrition Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Human Microbiome-based Gut Health Test and Nutrition Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Empower Your Decision-Making with 180 Pages Full Report @ www.insightaceanalytic.com/buy-report/1221

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.